{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:44:40Z","timestamp":1788025480720,"version":"build-2784847793"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11173-z","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:51:15Z","timestamp":1761054675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phage therapy for Drug-Resistant infections: Mechanisms, Evidence, and emerging clinical strategies"],"prefix":"10.1007","volume":"52","author":[{"given":"Rana","family":"Alaaeddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabras H.","family":"Al-Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyachandran","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fayyad-Kazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"8","key":"11173_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PNTD.0013363","volume":"19","author":"M Assefa","year":"2025","unstructured":"Assefa M et al (2025) Emergence of extensively and pan-drug resistance in clinical bacterial isolates: a systematic scoping review from Ethiopian public health perspective. PLoS Negl Trop Dis 19(8). https:\/\/doi.org\/10.1371\/JOURNAL.PNTD.0013363","journal-title":"PLoS Negl Trop Dis"},{"key":"11173_CR2","doi-asserted-by":"publisher","unstructured":"Algammal AM, Behzadi P (2024) A Global Public Health Concern that Needs Perspective Combating Strategies and New Talented Antibiotics. Discov Med 36(188):1911\u20133. https:\/\/doi.org\/10.24976\/DISCOV.MED.202436188.177.","DOI":"10.24976\/DISCOV.MED.202436188.177."},{"issue":"no. 6","key":"11173_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/QCO.0000000000000966","volume":"36","author":"F Cosentino","year":"2023","unstructured":"Cosentino F, Viale P, Giannella M (2023) MDR\/XDR\/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa? Curr Opin Infect Dis 36(6):564\u2013571. https:\/\/doi.org\/10.1097\/QCO.0000000000000966","journal-title":"Curr Opin Infect Dis"},{"key":"11173_CR4","doi-asserted-by":"publisher","unstructured":"Almutairy B (2024) Extensively and multidrug-resistant bacterial strains: case studies of antibiotics resistance. Front Microbiol 15:1381511. https:\/\/doi.org\/10.3389\/FMICB.2024.1381511\/FULL","DOI":"10.3389\/FMICB.2024.1381511\/FULL"},{"key":"11173_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jhin.2025.06.006","volume":"162","author":"PY Woh","year":"2025","unstructured":"Woh PY, Zhang X (2025) The burden of ESKAPE pathogen-related hospital-acquired infections: clinical and financial perspective from a systematic review. J Hosp Infect 162:377\u2013385. https:\/\/doi.org\/10.1016\/j.jhin.2025.06.006","journal-title":"J Hosp Infect"},{"key":"11173_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS13030257","author":"T Karampatakis","year":"2024","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2024) Pan-genome plasticity and virulence factors: a natural treasure trove for acinetobacter baumannii. Antibiotics. https:\/\/doi.org\/10.3390\/ANTIBIOTICS13030257","journal-title":"Antibiotics"},{"key":"11173_CR7","doi-asserted-by":"publisher","unstructured":"Falagas ME, Asimotou CM, Zidrou M, Kontogiannis DS, Filippou C (2025) Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review. Microorganisms 13(7):1697. https:\/\/doi.org\/10.3390\/MICROORGANISMS13071697\/S1","DOI":"10.3390\/MICROORGANISMS13071697\/S1"},{"key":"11173_CR8","doi-asserted-by":"publisher","unstructured":"Murray CJ (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","DOI":"10.1016\/S0140-6736(21)02724-0"},{"issue":"10","key":"11173_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/S41579-024-01054-W","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller WR, Arias CA (2024) ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat Rev Microbiol 22(10):598\u2013616. https:\/\/doi.org\/10.1038\/S41579-024-01054-W","journal-title":"Nat Rev Microbiol"},{"key":"11173_CR10","doi-asserted-by":"publisher","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2025) Carbapenem-Resistant Acinetobacter baumannii: Virulence Factors, Molecular Epidemiology, and Latest Updates in Treatment Options. Microorganisms 13(9):1983. https:\/\/doi.org\/10.3390\/MICROORGANISMS13091983","DOI":"10.3390\/MICROORGANISMS13091983"},{"key":"11173_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2022.975616","volume":"13","author":"P Behzadi","year":"2022","unstructured":"Behzadi P et al (2022) Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens. Front Microbiol 13. https:\/\/doi.org\/10.3389\/FMICB.2022.975616","journal-title":"Front Microbiol"},{"key":"11173_CR12","doi-asserted-by":"publisher","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2025) Carbapenem-resistant Pseudomonas aeruginosa\u2019s resistome: pan-genomic plasticity, the impact of transposable elements and jumping genes. Antibiotics. https:\/\/doi.org\/10.3390\/ANTIBIOTICS14040353","DOI":"10.3390\/ANTIBIOTICS14040353"},{"issue":"8","key":"11173_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/J.TIM.2025.03.009","volume":"33","author":"BH Good","year":"2025","unstructured":"Good BH, Bhatt AS, McDonald MJ (2025) Unraveling the tempo and mode of horizontal gene transfer in bacteria. Trends Microbiol 33(8):853\u2013865. https:\/\/doi.org\/10.1016\/J.TIM.2025.03.009","journal-title":"Trends Microbiol"},{"key":"11173_CR14","doi-asserted-by":"publisher","unstructured":"Patel KM, Seed KD (2024) Sporadic phage defense in epidemic Vibrio cholerae mediated by the toxin-antitoxin system DarTG is countered by a phage-encoded antitoxin mimic. mBio 15(10):e00111\u2013e00124. https:\/\/doi.org\/10.1128\/MBIO.00111-24","DOI":"10.1128\/MBIO.00111-24"},{"key":"11173_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/J.MICPATH.2024.107088","volume":"197","author":"DB Olawade","year":"2024","unstructured":"Olawade DB et al (2024) Phage therapy: a targeted approach to overcoming antibiotic resistance. Microb Pathog 197. https:\/\/doi.org\/10.1016\/J.MICPATH.2024.107088","journal-title":"Microb Pathog"},{"issue":"6","key":"11173_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1473-3099(25)00210-5","volume":"25","author":"T Burki","year":"2025","unstructured":"Burki T (2025) The history of phage therapy. Lancet Infect Dis 25(6):615. https:\/\/doi.org\/10.1016\/S1473-3099(25)00210-5","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"11173_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/S41564-024-01705-X","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay JP et al (2024) Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat Microbiol 9(6):1434\u20131453. https:\/\/doi.org\/10.1038\/S41564-024-01705-X","journal-title":"Nat Microbiol"},{"key":"11173_CR18","doi-asserted-by":"crossref","unstructured":"Dedrick RM et al (2019) Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nature Medicine 2019 25:5 25(5):730\u2013733 (10.1038\/s41591-019-0437-z.)","DOI":"10.1038\/s41591-019-0437-z"},{"issue":"9","key":"11173_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS13090870","volume":"13","author":"L Cui","year":"2024","unstructured":"Cui L et al (2024) A comprehensive review on phage therapy and phage-based drug development. Antibiotics 13(9). https:\/\/doi.org\/10.3390\/ANTIBIOTICS13090870","journal-title":"Antibiotics"},{"key":"11173_CR20","doi-asserted-by":"publisher","unstructured":"Bleriot I (2024) Improving phage therapy by evasion of phage resistance mechanisms. JAC-Antimicrobial Resistance 6(1). https:\/\/doi.org\/10.1093\/JACAMR\/DLAE017","DOI":"10.1093\/JACAMR\/DLAE017"},{"key":"11173_CR21","doi-asserted-by":"publisher","unstructured":"Liu H, Hu Z, Li M, Yang Y, Lu S, Rao X (2023) Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria. J Biomed Sci 30(1):1\u201318. https:\/\/doi.org\/10.1186\/S12929-023-00919-1\/FIGURES\/4","DOI":"10.1186\/S12929-023-00919-1\/FIGURES\/4"},{"key":"11173_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJBIOMAC.2025.146159","volume":"321","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Lan W, Sun X (2025) Phage-encoded depolymerases and endolysins as prospective strategies to combat multidrug-resistant Klebsiella pneumoniae. Int J Biol Macromol 321. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2025.146159","journal-title":"Int J Biol Macromol"},{"key":"11173_CR23","doi-asserted-by":"publisher","unstructured":"Cahill J, Young R (2019) Phage Lysis: Multiple Genes for Multiple Barriers. Adv Virus Res 103:33\u201370. https:\/\/doi.org\/10.1016\/BS.AIVIR.2018.09.003","DOI":"10.1016\/BS.AIVIR.2018.09.003"},{"key":"11173_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2023.1172635","volume":"14","author":"HJ Jia","year":"2023","unstructured":"Jia HJ, Jia PP, Yin S, Bu LK, Yang G, Pei DS (2023) Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions. Front Microbiol 14. https:\/\/doi.org\/10.3389\/FMICB.2023.1172635","journal-title":"Front Microbiol"},{"key":"11173_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00066-18","author":"FL Gordillo Altamirano","year":"2019","unstructured":"Gordillo Altamirano FL, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00066-18","journal-title":"Clin Microbiol Rev"},{"key":"11173_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/FCIMB.2022.907314","volume":"12","author":"L Plumet","year":"2022","unstructured":"Plumet L et al (2022) Bacteriophage therapy for Staphylococcus aureus infections: a review of animal models, treatments, and clinical trials. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/FCIMB.2022.907314","journal-title":"Front Cell Infect Microbiol"},{"key":"11173_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFAA389","author":"S Aslam","year":"2020","unstructured":"Aslam S (2020) Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/OFID\/OFAA389","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"11173_CR28","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/S00253-017-8224-6","volume":"101","author":"A Latka","year":"2017","unstructured":"Latka A, Maciejewska B, Majkowska-Skrobek G, Briers Y, Drulis-Kawa Z (2017) Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process. Appl Microbiol Biotechnol 101(8):3103\u20133119. https:\/\/doi.org\/10.1007\/S00253-017-8224-6","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"11173_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/J.RESMIC.2018.05.001","volume":"169","author":"N Hoyle","year":"2018","unstructured":"Hoyle N et al (2018) Phage therapy against achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report. Res Microbiol 169(9):540\u2013542. https:\/\/doi.org\/10.1016\/J.RESMIC.2018.05.001","journal-title":"Res Microbiol"},{"key":"11173_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/V13010060","author":"D Lebeaux","year":"2021","unstructured":"Lebeaux D (2021) A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient. Viruses. https:\/\/doi.org\/10.3390\/V13010060","journal-title":"Viruses"},{"issue":"1","key":"11173_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/EMPH\/EOY005","volume":"2018","author":"BK Chan","year":"2018","unstructured":"Chan BK, Turner PE, Kim S, Mojibian HR, Elefteriades JA, Narayan D (2018) Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol Med Public Health 2018(1):60\u201366. https:\/\/doi.org\/10.1093\/EMPH\/EOY005","journal-title":"Evol Med Public Health"},{"issue":"6","key":"11173_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5604\/01.3001.0015.0084","volume":"75","author":"KG Dobretsov","year":"2021","unstructured":"Dobretsov KG, Kolenchukova O, Sipkin A, Bellussi LM, Ciprandi G, Passali D (2021) A randomized, double-blind, placebo- -controlled study to investigate the use of bacteriophages in patients with chronic rhinosinusitis with nasal polyps. Otolaryngol Pol 75(6):33\u201337. https:\/\/doi.org\/10.5604\/01.3001.0015.0084","journal-title":"Otolaryngol Pol"},{"issue":"6","key":"11173_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS14060581","volume":"14","author":"AO Abedi","year":"2025","unstructured":"Abedi AO, Abedi AA, Ferry T, Citak M (2025) Current applications and the future of phage therapy for periprosthetic joint infections. Antibiotics 14(6). https:\/\/doi.org\/10.3390\/ANTIBIOTICS14060581","journal-title":"Antibiotics"},{"issue":"7","key":"11173_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/INF.0000000000004364","volume":"43","author":"M Gashaw","year":"2024","unstructured":"Gashaw M et al (2024) Neonatal sepsis due to multidrug-resistant bacteria at a tertiary teaching hospital in Ethiopia. Pediatr Infect Dis J 43(7):687\u2013693. https:\/\/doi.org\/10.1097\/INF.0000000000004364","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"11173_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS12040751","volume":"12","author":"K Diallo","year":"2023","unstructured":"Diallo K, Dublanchet A (2023) A century of clinical use of phages: a literature review. Antibiotics 12(4). https:\/\/doi.org\/10.3390\/ANTIBIOTICS12040751","journal-title":"Antibiotics"},{"key":"11173_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS9070377","author":"CA Duplessis","year":"2020","unstructured":"Duplessis CA, Biswas B (2020) A review of topical phage therapy for chronically infected wounds and preparations for a randomized adaptive clinical trial evaluating topical phage therapy in chronically infected diabetic foot ulcers. Antibiotics. https:\/\/doi.org\/10.3390\/ANTIBIOTICS9070377","journal-title":"Antibiotics"},{"key":"11173_CR37","doi-asserted-by":"publisher","unstructured":"Schooley RT et al (2017) Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother 61(10). https:\/\/doi.org\/10.1128\/AAC.00954-17\/SUPPL_FILE\/ZAC010176597S1.PDF","DOI":"10.1128\/AAC.00954-17\/SUPPL_FILE\/ZAC010176597S1.PDF"},{"key":"11173_CR38","doi-asserted-by":"publisher","unstructured":"Salyer CE, Bomholt C, Beckmann N, Bergmann CB, Plattner CA, Caldwell CC (2021) Novel therapeutics for the treatment of burn infection. Surg Infect (Larchmt) 22(1):113\u2013120. https:\/\/doi.org\/10.1089\/SUR.2020.104","DOI":"10.1089\/SUR.2020.104"},{"issue":"5","key":"11173_CR39","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/S41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan BK (2025) Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat Med 31(5):1494\u20131501. https:\/\/doi.org\/10.1038\/S41591-025-03678-8","journal-title":"Nat Med"},{"issue":"1","key":"11173_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/ECOSALPLUS.ESP-0029-2023","volume":"12","author":"JJ Zulk","year":"2024","unstructured":"Zulk JJ, Patras KA, Maresso AW (2024) The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus 12(1). https:\/\/doi.org\/10.1128\/ECOSALPLUS.ESP-0029-2023","journal-title":"EcoSal Plus"},{"issue":"1","key":"11173_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/S12985-017-0849-7","volume":"14","author":"A Wernicki","year":"2017","unstructured":"Wernicki A, Nowaczek A, Urban-Chmiel R (2017) Bacteriophage therapy to combat bacterial infections in poultry. Virol J 14(1). https:\/\/doi.org\/10.1186\/S12985-017-0849-7","journal-title":"Virol J"},{"key":"11173_CR42","doi-asserted-by":"publisher","unstructured":"Mao X et al (2023) Oral phage therapy with microencapsulated phage A221 against Escherichia coli infections in weaned piglets. BMC Vet Res 19(1):1\u201314. https:\/\/doi.org\/10.1186\/S12917-023-03724-Y\/FIGURES\/8.","DOI":"10.1186\/S12917-023-03724-Y\/FIGURES\/8."},{"issue":"1","key":"11173_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01652176.2024.2350661","volume":"44","author":"R Braunstein","year":"2024","unstructured":"Braunstein R et al (2024) Successful phage-antibiotic therapy of P. aeruginosa implant-associated infection in a Siamese cat. Vet Q 44(1):1\u20139. https:\/\/doi.org\/10.1080\/01652176.2024.2350661","journal-title":"Vet Q"},{"key":"11173_CR44","doi-asserted-by":"publisher","unstructured":"Romero J et al (2024) Lysin and Lytic Phages Reduce Vibrio Counts in Live Feed and Fish Larvae. Microorganisms 12(5):904. https:\/\/doi.org\/10.3390\/MICROORGANISMS12050904\/S1","DOI":"10.3390\/MICROORGANISMS12050904\/S1"},{"key":"11173_CR45","doi-asserted-by":"publisher","unstructured":"\u00c7a\u011fatay IT (2023) Bacteriophage applications in aquaculture. Israeli J Aquaculture - Bamidgeh 75(2):1\u201326. https:\/\/doi.org\/10.46989\/001C.78119","DOI":"10.46989\/001C.78119"},{"key":"11173_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/S12866-025-03803-0","author":"H Ding","year":"2025","unstructured":"Ding H et al (2025) Two virulent Vibrio Campbellii phages with potential for phage therapy in aquaculture. BMC Microbiol. https:\/\/doi.org\/10.1186\/S12866-025-03803-0","journal-title":"BMC Microbiol"},{"key":"11173_CR47","doi-asserted-by":"publisher","unstructured":"Elgendy MY, Ali SE, Dayem AA, Khalil RH, Moustafa MM, Abdelsalam M (2024) Alternative therapies recently applied in controlling farmed fish diseases: mechanisms, challenges, and prospects. Aquacult Int 32(7):9017\u20139078. https:\/\/doi.org\/10.1007\/S10499-024-01603-3\/FIGURES\/11","DOI":"10.1007\/S10499-024-01603-3\/FIGURES\/11"},{"key":"11173_CR48","doi-asserted-by":"publisher","unstructured":"Ul Haq I, Khan M, Khan I (2024) Phytopathological management through bacteriophages: enhancing food security amidst climate change. J Ind Microbiol Biotechnol 51. https:\/\/doi.org\/10.1093\/JIMB\/KUAE031","DOI":"10.1093\/JIMB\/KUAE031"},{"issue":"1","key":"11173_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/S43141-023-00549-Y","volume":"21","author":"EM Halawa","year":"2023","unstructured":"Halawa EM (2023) Challenges of bacteriophages application in controlling bacterial plant diseases and how to overcome them. J Genetic Eng Biotechnol 21(1). https:\/\/doi.org\/10.1186\/S43141-023-00549-Y","journal-title":"J Genetic Eng Biotechnol"},{"key":"11173_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2019.02813","volume":"10","author":"B \u00c1lvarez","year":"2019","unstructured":"\u00c1lvarez B, L\u00f3pez MM, Biosca EG (2019) Biocontrol of the major plant pathogen Ralstonia solanacearum in irrigation water and host plants by novel waterborne lytic bacteriophages. Front Microbiol 10. https:\/\/doi.org\/10.3389\/FMICB.2019.02813","journal-title":"Front Microbiol"},{"key":"11173_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/J.PLANTSCI.2024.112164","volume":"346","author":"IU Haq","year":"2024","unstructured":"Haq IU, Rahim K, Paker NP (2024) Exploring the historical roots, advantages and efficacy of phage therapy in plant diseases management. Plant Sci 346. https:\/\/doi.org\/10.1016\/J.PLANTSCI.2024.112164","journal-title":"Plant Sci"},{"key":"11173_CR52","doi-asserted-by":"publisher","unstructured":"Biosca EG et al (2024) First European Erwinia amylovora Lytic Bacteriophage Cocktails Effective in the Host: Characterization and Prospects for Fire Blight Biocontrol. Biology (Basel) 13(3):176. https:\/\/doi.org\/10.3390\/BIOLOGY13030176\/S1","DOI":"10.3390\/BIOLOGY13030176\/S1"},{"key":"11173_CR53","doi-asserted-by":"publisher","unstructured":"Born Y, Bosshard L, Duffy B, Loessner MJ, Fieseler L (2015) Protection of Erwinia amylovora bacteriophage Y2 from UV-induced damage by natural compounds. Bacteriophage 5(4). https:\/\/doi.org\/10.1080\/21597081.2015.1074330","DOI":"10.1080\/21597081.2015.1074330"},{"key":"11173_CR54","doi-asserted-by":"publisher","unstructured":"Barrero-Canosa J et al (2023) Characterization of phage vB_EcoS-EE09 infecting E. coli DSM613 Isolated from Wastewater Treatment Plant Effluent and Comparative Proteomics of the Infected and Non-Infected Host. Microorganisms 11(11):2688. https:\/\/doi.org\/10.3390\/MICROORGANISMS11112688\/S1","DOI":"10.3390\/MICROORGANISMS11112688\/S1"},{"key":"11173_CR55","doi-asserted-by":"publisher","unstructured":"Soliman RM, Othman BA, Shoman SA, Azzam MI, Gado MM (2023) Biocontrol of multi-drug resistant pathogenic bacteria in drainage water by locally isolated bacteriophage. BMC Microbiol 23(1):1\u201311. https:\/\/doi.org\/10.1186\/S12866-023-02847-4\/FIGURES\/5","DOI":"10.1186\/S12866-023-02847-4\/FIGURES\/5"},{"key":"11173_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCITOTENV.2023.164708","author":"J Pires","year":"2023","unstructured":"Pires J, Santos R, Monteiro S (2023) Antibiotic resistance genes in bacteriophages from wastewater treatment plant and hospital wastewaters. Sci Total Environ. https:\/\/doi.org\/10.1016\/J.SCITOTENV.2023.164708","journal-title":"Sci Total Environ"},{"key":"11173_CR57","doi-asserted-by":"publisher","unstructured":"Hu M et al (2023) A Meta-Analysis and Systematic Review of Listeria monocytogenes Response to Sanitizer Treatments. Foods 12(1):154. https:\/\/doi.org\/10.3390\/FOODS12010154\/S1","DOI":"10.3390\/FOODS12010154\/S1"},{"key":"11173_CR58","doi-asserted-by":"publisher","unstructured":"Shahdadi M, Safarirad M, Berizi E, Hosseinzadeh S, Phimolsiripol Y, Mousavi Khaneghah A (2024) Investigating the effect of phage on reducing Salmonella spp. in poultry meat: a systematic review and meta-analysis. Food Control 160. https:\/\/doi.org\/10.1016\/J.FOODCONT.2024.110380","DOI":"10.1016\/J.FOODCONT.2024.110380"},{"issue":"3","key":"11173_CR59","doi-asserted-by":"publisher","DOI":"10.4161\/BACT.25697","volume":"3","author":"J Woolston","year":"2013","unstructured":"Woolston J et al (2013) Bacteriophages lytic for Salmonella rapidly reduce Salmonella contamination on glass and stainless steel surfaces. Bacteriophage 3(3). https:\/\/doi.org\/10.4161\/BACT.25697","journal-title":"Bacteriophage"},{"key":"11173_CR60","doi-asserted-by":"publisher","unstructured":"El Haddad L, Mendoza JF, Jobin C (2022) Bacteriophage-mediated manipulations of microbiota in gastrointestinal diseases. Front Microbiol 13:1055427. https:\/\/doi.org\/10.3389\/FMICB.2022.1055427\/XML","DOI":"10.3389\/FMICB.2022.1055427\/XML"},{"issue":"1","key":"11173_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41538-023-00245-8","volume":"8","author":"SA Ranveer","year":"2024","unstructured":"Ranveer SA (2024) Positive and negative aspects of bacteriophages and their immense role in the food chain. NPJ Sci Food 8(1):1\u201313. https:\/\/doi.org\/10.1038\/S41538-023-00245-8","journal-title":"NPJ Sci Food"},{"key":"11173_CR62","doi-asserted-by":"publisher","unstructured":"Lu H, Li Z, Elbaz A, Ni SQ (2023) Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms. BMC Microbiol 23(1):1\u201313. https:\/\/doi.org\/10.1186\/S12866-023-02881-2\/FIGURES\/6","DOI":"10.1186\/S12866-023-02881-2\/FIGURES\/6"},{"issue":"6","key":"11173_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES27061857","volume":"27","author":"J Lin","year":"2022","unstructured":"Lin J, Du F, Long M, Li P (2022) Limitations of phage therapy and corresponding optimization strategies: a review. Molecules 27(6). https:\/\/doi.org\/10.3390\/MOLECULES27061857","journal-title":"Molecules"},{"key":"11173_CR64","doi-asserted-by":"publisher","unstructured":"Yang Q, Le S, Zhu T, Wu N (2023) Regulations of phage therapy across the world. Front Microbiol 14:1250848. https:\/\/doi.org\/10.3389\/FMICB.2023.1250848\/BIBTEX","DOI":"10.3389\/FMICB.2023.1250848\/BIBTEX"},{"key":"11173_CR65","doi-asserted-by":"publisher","unstructured":"Sawa T, Moriyama K, Kinoshita M (2024) Current status of bacteriophage therapy for severe bacterial infections. J Intensive Care 12(1):1\u20139. https:\/\/doi.org\/10.1186\/S40560-024-00759-7\/TABLES\/3","DOI":"10.1186\/S40560-024-00759-7\/TABLES\/3"},{"key":"11173_CR66","doi-asserted-by":"publisher","unstructured":"Siopi M et al (2024) Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Rev 37(3). https:\/\/doi.org\/10.1128\/CMR.00044-24\/SUPPL_FILE\/CMR.00044-24-S0009.PDF","DOI":"10.1128\/CMR.00044-24\/SUPPL_FILE\/CMR.00044-24-S0009.PDF"},{"key":"11173_CR67","doi-asserted-by":"publisher","unstructured":"Zalewska-Pi\u0105tek B (2023) Phage therapy\u2014challenges, opportunities and future prospects. Pharmaceuticals 16(12). https:\/\/doi.org\/10.3390\/PH16121638","DOI":"10.3390\/PH16121638"},{"key":"11173_CR68","doi-asserted-by":"publisher","unstructured":"Berryhill BA, Gil-Gil T, Smith AP, Levin BR (2025) The future of phage therapy in the USA. Trends Mol Med. https:\/\/doi.org\/10.1016\/J.MOLMED.2025.03.013","DOI":"10.1016\/J.MOLMED.2025.03.013"},{"issue":"1","key":"11173_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.CELL.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT (2023) Phage therapy: From biological mechanisms to future directions. Cell 186(1):17. https:\/\/doi.org\/10.1016\/J.CELL.2022.11.017","journal-title":"Cell"},{"key":"11173_CR70","doi-asserted-by":"publisher","unstructured":"Yang P et al (2025) Novel delivery systems for phages and lysins in the topical management of wound infections: a narrative review. Front Microbiol 16:1526096. https:\/\/doi.org\/10.3389\/FMICB.2025.1526096\/BIBTEX","DOI":"10.3389\/FMICB.2025.1526096\/BIBTEX"},{"key":"11173_CR71","doi-asserted-by":"publisher","unstructured":"Wang H et al (2024) Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. Journal of Nanobiotechnology  22(1):1\u201331. https:\/\/doi.org\/10.1186\/S12951-024-02576-4.","DOI":"10.1186\/S12951-024-02576-4."},{"key":"11173_CR72","doi-asserted-by":"publisher","unstructured":"Lou Y-R, Xavier NM, Zalewska-Pi B (2023) Phage Therapy\u2014Challenges, Opportunities and Future Prospects. Pharmaceuticals 16(12):1638. https:\/\/doi.org\/10.3390\/PH16121638","DOI":"10.3390\/PH16121638"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11173-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11173-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11173-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:05:36Z","timestamp":1766898336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11173-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11173"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11173-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"\u201cThis article does not contain any studies with human participants performed by any of the authors.\u201d","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work the authors used ChatGPT to improve language and readability. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI-assisted."}}],"article-number":"1051"}}